Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases - 1 Jul 2007

Carvajal-Rodríguez Antonio, Crandall Keith A, Posada David

Abstract excerpt

We studied the relationship between recombination and the fixation time of multiple drug resistance mutations after HIV-1 drug therapy, under a set of different realistic scenarios. We have generalized a previous model by Bretscher et al. [Bretscher, Althaus, Muller, Bonhoeffer, 2004. Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26(2), 180-188] in order to explore...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Evolution, Molecular

Share to Models, Biological

Share to Mutation

Share to Recombination, Genetic

Share to Stochastic Processes

Source

Open in PubMed Open full text

Identifiers

PMID: 17369105
DOI: 10.1016/j.meegid.2007.02.001
PMCID: PMC2041866

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy.PMID 17369105Read ↗

Recombination and drug resistance in HIV: population dynamics and stochasticity.Semantic proximity Read ↗

Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1.Semantic proximity Read ↗

HIV recombination: what is the impact on antiretroviral therapy?Semantic proximity Read ↗

Recombination rate and selection strength in HIV intra-patient evolution.Semantic proximity Read ↗

Genetic Consequences of Antiviral Therapy on HIV-1.Semantic proximity Read ↗

Recombination increases human immunodeficiency virus fitness, but not necessarily diversity.Semantic proximity Read ↗

Mathematical approaches in the study of viral kinetics and drug resistance in HIV-1 infection.Semantic proximity Read ↗

Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity.Semantic proximity Read ↗

Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral TreatmentSemantic proximity Read ↗

Influence of mutation and recombination on HIV-1 in vitro fitness recovery.Semantic proximity Read ↗

Emergence of recombinant forms of HIV: dynamics and scaling.Semantic proximity Read ↗

Fitness variations and their impact on the evolution of antiretroviral drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.